Plasma-First to Accelerate Time to Treatment and Improve Target Detection in Advanced Lung Cancer: A Prospective Study

M. Garcia Pardo,K. Czarnecka,J. H. Law,Z. J. Fan,T. K. Waddell,K. Yasufuku,G. Liu,L. L. Donahoe,A. Pierre,L. W. Le, T. Gunasegaran, N. Ghumman,P. A. Bradbury,F. Shepherd,A. Sacher,L. Corke, J. Feng,T. Stockley,P. Pal,P. Rogalla,C. Pipinikas, K. D. Howarth,M. Tsao,N. B. Leighl

Journal of Thoracic Oncology（2023）

Cited 0|Views39

No score

Abstract

Liquid biopsy is emerging as a complement to tumor tissue profiling in advanced non-small-cell lung cancer (NSCLC) patients. We prospectively evaluated the use of a plasma-first approach in the initial diagnostic work-up of patients with suspected advanced NSCLC (NCT04862924).

Translated text

Key words

NSCLC,liquid biopsy,plasma-first

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined